Medication info

Hutex Ranitidine Tablet 150 mg (Ranitidine Hydrochloride)

Prescription medicationApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›Strength being verified
Manufacturer / importer
Korea Hutex Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201404834 · Approved 2014.10.22

This product's status changed to Approval withdrawn on 2023.05.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as gastric ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who uses it
Adults · Children
Adult dosage
Administer 150 mg of ranitidine per dose twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medication per dose twice daily orally, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg per dose twice daily, in the morning and at bedtime. The same dosage applies to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drug use or to prevent gastric and duodenal ulcers during long-term nonsteroidal anti-inflammatory drug use. Healing usually occurs within 4 weeks; for conditions caused by nonsteroidal anti-inflammatory drug use, healing usually occurs within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg per dose twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg per dose 3 times daily, and increase as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injectable preparation. Once oral administration is possible, switch to oral administration and give 150 mg of this medication per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this medication 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis. Administer 150 mg of this medication per dose once daily at bedtime. 7) Hyperacidity, heartburn, acid regurgitation: In patients aged 12 years and older, administer 75 mg of this medication per dose twice daily orally (for oral solution only). 3. Patients with renal impairment In patients with severe renal impairment with creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
8 〜 18 years: 150 mg per dose (2 mg per kg body weight), up to twice daily

Ingredients

Manufacturer
Korea Hutex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as gastric ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAID administration
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This drug is used for ulcers of the stomach and duodenum, Zollinger-Ellison syndrome, gastroesophageal reflux disease, etc. It is also effective in preventing Mendelson's syndrome before surgery and treating ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) after surgery. It helps improve exacerbations of acute and chronic gastritis, gastric mucosal lesions, and upper gastrointestinal bleeding. It can also be used to relieve symptoms such as excessive gastric acid, heartburn, and regurgitation. This medication is effective in treating various gastrointestinal diseases and symptoms.

Dosage and Administration

Adult dosage

Administer 150 mg of ranitidine per dose twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medication per dose twice daily orally, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg per dose twice daily, in the morning and at bedtime. The same dosage applies to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drug use or to prevent gastric and duodenal ulcers during long-term nonsteroidal anti-inflammatory drug use. Healing usually occurs within 4 weeks; for conditions caused by nonsteroidal anti-inflammatory drug use, healing usually occurs within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg per dose twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg per dose 3 times daily, and increase as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injectable preparation. Once oral administration is possible, switch to oral administration and give 150 mg of this medication per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this medication 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis. Administer 150 mg of this medication per dose once daily at bedtime. 7) Hyperacidity, heartburn, acid regurgitation: In patients aged 12 years and older, administer 75 mg of this medication per dose twice daily orally (for oral solution only). 3. Patients with renal impairment In patients with severe renal impairment with creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

8 〜 18 years: 150 mg per dose (2 mg per kg body weight), up to twice daily

Precautions

This drug should not be used in patients with allergies to its components or a history of acute porphyria. In patients with impaired renal function, the concentration of this drug may increase, requiring dose adjustment, and caution should also be exercised in patients with decreased liver function. Patients with a history of drug allergic reactions or the elderly should be administered this drug with caution, especially when taking nonsteroidal anti-inflammatory drugs concurrently. This drug may mask the symptoms of gastric cancer; therefore, in patients with gastric ulcers or new or changed dyspeptic symptoms in middle-aged or older individuals, it should be used only after confirming the malignancy. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should also receive bacterial treatment. When using this medication, severe allergic reactions, blood disorders, liver dysfunction, heart problems, gastrointestinal symptoms, and neurological abnormalities may occur; therefore, symptoms should be monitored closely. Particularly, if dizziness or drowsiness occurs, it is advisable to avoid driving or operating dangerous machinery. This drug may interact with other medications, so healthcare professionals should be informed of concurrent medications, and specific intervals between certain medications should be observed. Women who are pregnant or breastfeeding should thoroughly consider the benefits and risks of using this drug. Safety in children has not been adequately established, so caution is required, and elderly patients may require dose adjustments due to decreased renal function. In cases of overdose, appropriate treatment such as vomiting or gastric lavage is necessary, and in severe cases, blood dialysis may be done to remove the drug. When storing this drug, keep it out of reach of children and do not transfer it to another container. This drug may promote bacterial growth in the stomach by reducing acid secretion; therefore, regular monitoring, including ophthalmic examinations, is necessary during long-term use.

Side effects

  • anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 55 more
  • leukopenia
  • thrombocytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic marrow
  • hypoplastic anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • feeling of heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • muscular cramps
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container that prevents light and kept in a dry place at room temperature between 1 degree and 30 degrees. Storing it this way can help maintain the drug's efficacy for a longer time.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.